New devices aim to ease cold symptoms – but will they work?

NCT ID NCT07383493

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing four medical devices (PIR, NS, NHE, NHG) in 150 adults with acute viral rhinitis, rhinosinusitis, or rhinopharyngitis (common cold). The goal is to see if they are safe and help reduce symptoms like sneezing, runny nose, and sore throat. Participants use the device for up to 14 days and report any side effects and symptom changes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
medical devices (PIR, NS, NHE, NHG)
What this could lead to
If successful, this could confirm that these devices safely reduce symptoms like runny nose and congestion for people with common colds.
What could go wrong
This is a small, early-stage study with no placebo group, so results may not prove the devices work better than doing nothing. Side effects are possible but not well understood yet.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHINITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Plateforme d'investigation clinique/Centre d'Investigation Clinique, Inserm CIC 1405

    RECRUITING

    Clermont-Ferrand, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.